The Veterinary Medicines Directorate (VMD) is monitoring the availability of authorised veterinary medicines in the UK during the coronavirus (COVID-19) outbreak.
The VMD and the pharmaceutical industry have well-established procedures to deal with supply issues that arise. These procedures include robust, intelligence-led warning systems to detect potential problems at the earliest possible point and an emergency response plan to support the continued supply of veterinary medicines. We work closely with the veterinary pharmaceutical industry and those operating in the supply chain to minimise risks when they do arise.
